Jerzy Jankun Selected Research

Jerzy Jankun Research Topics

Disease

25	Neoplasms (Cancer) 01/2019 - 01/2003
15	Prostatic Neoplasms (Prostate Cancer) 01/2015 - 03/2003
10	Neoplasm Metastasis (Metastasis) 01/2019 - 01/2003
7	Hemorrhage 06/2015 - 07/2009
6	Wounds and Injuries (Trauma) 01/2015 - 11/2007
5	Thrombosis (Thrombus) 06/2015 - 07/2009
5	Obesity 01/2014 - 07/2010
3	Carcinogenesis 10/2012 - 07/2003
2	Cardiovascular Diseases (Cardiovascular Disease) 05/2016 - 01/2012
2	Lung Neoplasms (Lung Cancer) 05/2016 - 01/2010
2	Chronic Renal Insufficiency 02/2014 - 03/2013
2	Diabetic Nephropathies (Diabetic Nephropathy) 10/2012 - 01/2012
2	Cachexia 07/2012 - 07/2012
2	Alzheimer Disease (Alzheimer's Disease) 04/2011 - 07/2010
1	Trisomy (Trisomies) 01/2018
1	Down Syndrome (Down's Syndrome) 01/2018
1	Mouth Neoplasms (Oral Cancer) 07/2015
1	Pathologic Processes 04/2014
1	Persistent Infection 04/2014
1	Periodontitis 04/2014
1	Iron-Deficiency Anemia (Anemia, Iron Deficiency) 02/2014
1	Myocardial Infarction 02/2014
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2014
1	Carcinoma (Carcinomatosis) 01/2014
1	Colonic Neoplasms (Colon Cancer) 01/2014
1	Kidney Diseases (Kidney Disease) 03/2013
1	Kidney Neoplasms (Kidney Cancer) 10/2012
1	Hypertension (High Blood Pressure) 10/2012
1	Renal Cell Carcinoma (Grawitz Tumor) 10/2012
1	Malnutrition (Nutritional Deficiencies) 07/2012
1	Type 2 Diabetes Mellitus (MODY) 01/2012
1	Insulin Resistance 01/2012
1	Vascular Remodeling 04/2011
1	Intraoperative Complications 10/2010
1	Barrett Esophagus (Barrett's Esophagus) 09/2010
1	Adenocarcinoma 09/2010
1	Body Weight (Weight, Body) 07/2010
1	Disease Susceptibility (Diathesis) 07/2010

Drug/Important Bio-Agent (IBA)

21	Plasminogen Activator Inhibitor 1IBA 07/2015 - 01/2003
11	Plasminogen InactivatorsIBA 06/2015 - 01/2003
8	PlasminogenIBA 01/2019 - 01/2010
6	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 07/2015 - 01/2003
6	Arachidonate 12-Lipoxygenase (12 Lipoxygenase)IBA 01/2014 - 05/2006
5	Fibrinolysin FDA Link 01/2018 - 07/2007
5	Proteins (Proteins, Gene)FDA Link 06/2015 - 06/2009
5	1-phenyl-3,3-dimethyltriazene (PDT)IBA 10/2011 - 03/2003
4	EnzymesIBA 01/2019 - 08/2006
4	Photosensitizing Agents (Photosensitizers)IBA 10/2011 - 03/2003
3	Peptide Hydrolases (Proteases)FDA Link 01/2019 - 07/2015
3	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2018 - 07/2009
3	CurcuminIBA 05/2016 - 07/2003
3	Hemostatics (Antihemorrhagics)IBA 06/2015 - 07/2010
3	TeaIBA 01/2015 - 07/2010
2	Metalloproteases (Metalloproteinases)IBA 01/2019 - 01/2018
2	Matrix Metalloproteinases (MMPs)IBA 01/2019 - 01/2018
2	PolyphenolsIBA 01/2018 - 07/2010
2	Antifibrinolytic Agents (Antifibrinolytics)IBA 06/2015 - 01/2010
2	SerpinsIBA 06/2015 - 01/2003
2	Biomarkers (Surrogate Marker)IBA 01/2014 - 10/2012
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2012 - 05/2006
2	Carnitine (L-Carnitine)FDA LinkGeneric 07/2012 - 07/2012
2	VitronectinIBA 01/2010 - 07/2007
2	AcidsIBA 02/2008 - 05/2006
2	Cysteine (L-Cysteine)FDA Link 07/2007 - 01/2003
2	Antineoplastic Agents (Antineoplastics)IBA 07/2007 - 01/2003
1	Nerve Growth Factor (NGF)IBA 01/2018
1	Dyrk KinasesIBA 01/2018
1	Aminocaproic Acid (6 Aminocaproic Acid)FDA LinkGeneric 06/2015
1	Glycoproteins (Glycoprotein)IBA 06/2015
1	Tranexamic Acid (AMCA)FDA Link 06/2015
1	Lysine (L-Lysine)FDA Link 06/2015
1	IronIBA 02/2014
1	SaltsIBA 02/2014
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2014
1	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 01/2014
1	Metformin (Glucophage)FDA LinkGeneric 01/2014
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 01/2014
1	Vascular Endothelial Growth Factor CIBA 01/2014
1	Vascular Endothelial Growth Factor DIBA 01/2014
1	Therapeutic UsesIBA 01/2014
1	AMP-Activated Protein KinasesIBA 01/2014
1	LipoxygenasesIBA 10/2012
1	Phosphotransferases (Kinase)IBA 10/2012
1	Plasminogen Activators (Plasminogen Activator)IBA 10/2012
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 07/2012
1	AntigensIBA 10/2011
1	HematoporphyrinsIBA 10/2011
1	AntibodiesIBA 09/2010
1	theaflavin digallateIBA 07/2010
1	recombinant FVIIa (rFVIIa)FDA Link 11/2007
1	NucleophosminIBA 07/2007
1	Urokinase Plasminogen Activator ReceptorsIBA 07/2007

Therapy/Procedure

8	Therapeutics 07/2015 - 08/2004
5	Photochemotherapy (Photodynamic Therapy) 10/2011 - 03/2003
1	Nephrectomy 01/2015
1	Chemoprevention 01/2014
1	Peritoneal Dialysis 03/2013
1	Renal Dialysis (Hemodialysis) 03/2013
1	Kidney Transplantation 03/2013
1	Drug Therapy (Chemotherapy) 10/2012